[ Price : $8.95]
Pfizer plans to share with FDA favorable data from its Phase 3 study of the antibody-drug conjugate Adcetris (brentuximab vedotin)...[ Price : $8.95]
Lexicon Pharmaceuticals says that after receiving recent FDA feedback it plans to resubmit its NDA for sotagliflozin oral tablets ...[ Price : $8.95]
Acadia Pharmaceuticals stops developing pimavanserin for treating negative symptoms of schizophrenia based on disappointing top-li...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Early Alzheimers Disease: Developing Drugs for Treatment....[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension on adverse experience reporting for licensed biologi...[ Price : $8.95]
Federal Register proposed rule: FDA proposes to revise the requirements for the content and format of labeling for approved or con...[ Price : $8.95]
Windstone Medical Packaging recalls its Local Lower Extremity Pack, In-House Ocular Pack and Closure Kit in response to Nurse Assi...[ Price : $8.95]
FDA sends Viatris/Mapi Pharma a complete response letter on the NDA for GA Depot 40 mg, a long-acting glatiramer acetate being inv...